Interview with Archer Materials (ASX:AXE) CTO Simon Ruffell

We spoke with Simon Ruffell, CTO of Archer Materials (ASX:AXE), about the near term milestones for the development of the Biochip and 12CQ. We also touched on the departure of CEO Couchair as well as the big opportunities in the market for the Biochip.

[@andywaterman6536]

Great much needed update on Archer...👍

[@1244izzy]

Great interview! But i have a question for Mr. Ruffle - Why are lead customers not already engaged for the biochip? Based on news releases it "appears" that it has reasonably high potential and it seems odd that mainstream investors arent banging on their doors. The absence of big name interests is very, very concerning.

[@garybargwanna1516]

As an investor it would be nice to know what is the cash burn rate, when do you anticipate some form of income, do you anticipate going to shareholders for capital, is there any other companies in your space and how further are they in their research etc,etc.